Search clinical trials for: WO3992

Total 4 results

Dr. August Wolff GmbH & Co. KG Arzneimittel
FGK Clinical Research GmbH; Nuvisan GmbH; Charles River Biopharmaceutical Services...

Completed

Investigation of Ascending Concentrations of Glycopyrronium Bromide (GPB) in a Topical Formulation in Subjects With Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis

Germany
Dr. August Wolff GmbH & Co. KG Arzneimittel

Completed

Assessment of Efficacy and Safety of Topical Administration of 1% Glycopyrronium Bromide (GPB) in Patients With Primary Axillary Hyperhidrosis and the Assessment of Long-term Efficacy and Safety of Topical Administration of 1% GPB Cream in Patients With Primary Axillary Hyperhidrosis.

Primary Axillary Hyperhidrosis

Germany
Dr. August Wolff GmbH & Co. KG Arzneimittel
Bremer Pharmacovigilance Service GmbH; PHARMALOG Institute for Clinical Research

Completed

Safety, Tolerability and Efficacy of Vaginal Suppository WO3191 in the Post-treatment of Bacterial Vaginosis

Vaginosis, Bacterial

Germany
Dr. August Wolff GmbH & Co. KG Arzneimittel
Therapeutics, Inc.

Not yet recruiting

Assessment of Safety, Tolerability and Efficacy of 1% GPB Cream Versus Qbrexza® (Glycopyrronium) Cloth 2.4% Under Maximum-Use Conditions in Subjects With Primary Axillary Hyperhidrosis

Primary Axillary Hyperhidrosis

3

Subscribe